As a raft of non-positive opinions on probiotics floats down the health claims river, questions have been asked of the efficacy of the beneficial bacteria. Two experts discuss where we stand and how to get the good ship Probiotic back on course.
Three of Europe’s largest food supplement and healthy product trade groups have issued a 17-page paper that lays out its many concerns with the scientific approach being taken by EFSA in regard to health claims.
Pooling nutrient information is becoming an important and time efficient way for companies seeking scientific data about nutrients – especially those seeking to back health claims under the European Union’s tough claims system.
A new partnership with chemical group Solvay will enable the distribution of a low dosage prebiotic food ingredient with multiple food and drink applications within Europe, the Middle East and Africa, claims Tate & Lyle.
Genetic typing, internationally recognised naming protocols and evidence of consistency in the final product have been highlighted by the European Food Safety Authority (EFSA) as critical factors for probiotic health claim submissions.
There is not enough evidence to support the claim that probiotics can remedy or prevent bacterial vaginosis (BV), according to a new study conducted jointly by scientists in the United Arab Emirates, Belgium and Italy.
Pan-European better nutrition advocate, the Alliance for Natural Health (ANH), says the European Union health claims system is going way beyond its remit to protect consumer interests and curtailing freedom of speech.
The European Commission has set itself the goal of processing the 94 generic article 13.1 health claim opinions issued by EFSA recently by the end of January, meaning claim rulings could be enforceable at retail level by July, 2010.